Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

ClinicalTrials.gov ID: NCT03522246

Public ClinicalTrials.gov record NCT03522246. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 12:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ATHENA (A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, randomized, multinational, double-blind, dual placebo-controlled, 4-arm study evaluating rucaparib and nivolumab as maintenance treatment following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based on homologous recombination (HR) status of tumor samples.

Study identification

NCT ID
NCT03522246
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
pharmaand GmbH
Industry
Enrollment
1,097 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 14, 2018 (Actual)
Primary completion
May 20, 2024 (Actual)
Completion
Dec 30, 2030 (Estimated)
Last update posted
Jun 24, 2025

2018 – 2030

United States locations

U.S. sites
64
U.S. states
31
U.S. cities
58
Facility City State ZIP Site status
Arizona Oncology Associates, PC - HAL Phoenix Arizona 85016 —
Arizona Oncology Associates, PC - HOPE Tucson Arizona 85711 —
The University of Arizona Cancer Center Tucson Arizona 85724 —
John Muir Clinical Research Center Concord California 94520 —
UCLA Women's Health Clinical Research Unit Los Angeles California 90095 —
Kaiser Permanente Northern California San Francisco California 94589 —
University of Colorado Cancer Center Aurora Colorado 80045 —
Rocky Mountain Cancer Centers Lakewood Colorado 80228 —
Yale University New Haven Connecticut 06520 —
Florida Gynecologic Oncology Fort Myers Florida 33905 —
MD Anderson Cancer Center-Baptist Jacksonville Florida 32207 —
Baptist Health Medical Group Oncology, LLC Miami Florida 33176 —
Florida Hospital Orlando Florida 32804 —
Northside Hospital Atlanta Georgia 30342 —
Augusta University Augusta Georgia 30912 —
Rush University Medical Center Chicago Illinois 60612 —
Dr. Sudarshan K. Sharma, Ltd - Gynecologic Oncology Hinsdale Illinois 60521 —
Ferrell-Duncan Clinic Springfield Illinois 62769 —
Community Health Network Indianapolis Indiana 46250 —
University of Iowa Hospitals Iowa City Iowa 52242 —
University of Kansas Cancer Center Westwood Kansas 66205 —
University of Kentucky Lexington Kentucky 40536 —
Norton Cancer Institute Louisville Kentucky 40241 —
Ochsner Medical Center New Orleans Louisiana 70121 —
Maine Medical Center Scarborough Maine 04074 —
SKCCC at Johns Hopkins Baltimore Maryland 21287 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Metro Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota 55416 —
Washington University School of Medicine St Louis Missouri 63110 —
Women's Cancer Center of Nevada Las Vegas Nevada 89169 —
MD Anderson Cancer Center at Cooper Camden New Jersey 08103 —
Summit Medical Group Florham Park New Jersey 07932 —
Women's Cancer Care Associates Albany New York 12008 —
Broome Oncology, LLC Johnson City New York 13790 —
Northwell Health Monter Cancer Center Lake Success New York 11042 —
New York University Medical Center New York New York 10016 —
University of North Carolina Chapel Hill North Carolina 27707 —
University of Cincinnati Cincinnati Ohio 45221 —
Oncology Hematology Care, Inc Cincinnati Ohio 45242 —
Cleveland Clinic Cleveland Ohio 44106 —
The Ohio State University Columbus Ohio 43210 —
MD Anderson Cancer Center - Ohio Health Columbus Ohio 44907 —
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104 —
Oklahoma Cancer Specialists and Research Institute Tulsa Oklahoma 74146 —
Oncology Associates of Oregon, P.C. Eugene Oregon 97401 —
LMG Gynecologic Oncology Portland Oregon 97210 —
Northwest Cancer Specialists, P.C. Portland Oregon 97225 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
UPMC Magee-Womens Hospital Pittsburgh Pennsylvania 15213 —
Abington Memorial Hospital Willow Grove Pennsylvania 19090 —
Avera Gynecologic Oncology Sioux Falls South Dakota 57105 —
Texas Oncology - Austin Central Austin Texas 78731 —
Texas Oncology - Bedford Bedford Texas 76022 —
Texas Oncology - Dallas Presbyterian Hospital Dallas Texas 75231 —
Texas Oncology - Fort Worth Fort Worth Texas 76104 —
Memorial Hermann Houston Texas 77030 —
University of Texas MD Anderson Cancer Center Houston Texas 77030 —
Texas Oncology - San Antonio Medical Center San Antonio Texas 78240 —
Texas Oncology - The Woodlands, Gynecologic Oncology The Woodlands Texas 77380 —
Huntsman Cancer Institute Salt Lake City Utah 84112 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Froedtert and Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 174 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03522246, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2025 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03522246 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →